Analysts Are Downgrading These 5 Pharmaceutical Stocks

Page 5 of 5

1. Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Number of Hedge Fund Holders: 18

Not a pure pharmaceutical stock per se, Sabra is a leading healthcare REIT that invests in skilled nursing, senior housing and behavioral health facilities. Barclays recently downgraded Sabra Health Care to Equal Weight from Overweight with a price target of $14, down from $16. The firm’s analyst Steve Valiquette thinks that skilled nursing facility overhangs are continuing to increase. The company also has lower than average rent coverage ratios according to the analyst.

For a look at some other interesting stocks that could make good additions to your own portfolio, check out 10 Best Dividend Stocks for College Students and 10 Best Biotech Stocks Under $5.

Follow Insider Monkey on Twitter

Page 5 of 5